Clinical trials: latest news

Clinical trials resources

  • Clinical trials

    A clinical trial is a study in which a new treatment is assessed.There are legal requirements on how a trial should be run.If you choose to join a...

    From: Factsheets

    Information level Level 2
  • Thinking about joining a clinical trial?

    Before you make a decision about joining a clinical trial, make sure you fully understand what’s involved.There will be benefits and risks to joining any clinical trial.Discuss...

    From: Factsheets

    Information level Level 2

Clinical trials features

Clinical trials in your own words

Clinical trials news from aidsmap

More news

Clinical trials news selected from other sources

  • Is It Safe to Interrupt HIV Treatment During Cure Studies?

    Previous research has shown that long interruptions are not safe—but what about shorter, more closely monitored gaps in treatment?

    17 July 2019 | POZ
  • HIV Vaccine Trials on Gay, Bi Men to Begin in U.S., Europe

    Around 3800 men who have sex with men will be part of Johnson & Johnson's historic vaccine trial.

    15 July 2019 | Advocate.com
  • EU Calls For Results Of All EU-based Clinical Trials To Be Added To Public Database

    The European Commission and European Union medicines regulatory agencies sent an open letter to all sponsors of EU-based clinical trials to remind them of their obligation to publish the results of the trials – both positive and negative – in a public database.

    07 July 2019 | Health Policy Watch
  • Can Self-Swabs Make HIV Exposure and Risk Reporting More Accurate?

    A new study conducted in South Africa finds that when cisgender women are given the tools to assess their HIV exposure risk at home, those tools can yield far more accurate results than a sit-down interview with an HIV clinician. The study also pioneered a new use case for swabbing kits, yielding valuable insights that lead author Maria Lemos, Ph.D., says may one day lead to a new method of self-testing for HIV exposure at home.

    01 July 2019 | The Body Pro
  • Breaking down HIV exclusions in cancer clinical trials

    As an eligibility barrier cracks, a lung cancer patient gets a new lease on life.

    10 June 2019 | Fred Hutchinson Cancer Research Center
  • Half of H.I.V. Patients Are Women. Most Research Subjects Are Men.

    Trials of vaccines and treatments have not included enough female participants. Now that scientists are exploring possible cures, the need to enroll women is greater than ever.

    31 May 2019 | New York Times
  • UCSD has not told women with HIV of data breach, despite researchers' pleas

    University of California San Diego officials stonewalled attempts to notify women in an HIV research study that their confidential data was breached more than seven months ago, an inewsource investigation has found. UCSD researchers conducting the EmPower Women study told university officials in October that participants’ names, audio-taped conversations and other sensitive materials were made accessible to everyone working at Christie’s Place, a San Diego nonprofit supporting women with HIV and AIDS.

    15 May 2019 | inewsource
  • Despite Uptick, Black and Latinx People Have Relatively Low Participation in HIV Vaccine Trials

    Black and Latinx people historically have not willfully participated in clinical trials in high numbers. Medical mistrust of research and health care institutions has long been a problem for conducting biomedical research. So what's causing the racial disparities in research participation, and what are researchers doing about it?

    14 May 2019 | The Body Pro
  • The largest study involving transgender people is providing long-sought insights about their health

    The research examines once taboo questions about the impacts of gender transition. The European Network for the Investigation of Gender Incongruence (ENIGI) is the largest scientific study of transgender people in the world, now with 2600 participants, and is unique because it is prospective, studying the impact of hormone and other therapies on their health over the long term.

    25 April 2019 | Nature
  • Why Do Study Participants Misreport Their HIV Status?

    Why do some study volunteers misreport their HIV status to researchers? Maybe they misunderstood the conditions for incentive payments or the question itself, speculated the authors of a recent study on the subject. Or maybe the questions were not phrased in a way that is easy for laypersons to understand, countered David Malebranche, M.D., M.P.H., of Morehouse School of Medicine.

    24 April 2019 | The Body Pro
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.